Anti-CEA CAR-T
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Anti-CEA CAR-T, covering 2022-04-01 to 2025-04-03. Get the full timeline:
Most recent: Clinical Trial Update: Anti-CEA CAR-T for Advanced CEA-Positive Lung Carcinoma [Phase 1]